[Contemporary methods of diagnosis and treatment of neuroendocrine gastrointestinal tumors].
Neuroendocrine tumors of digestive tract (GEP NET) occur rather rarely, causing many problems with both diagnosis and treatment. Thanks to the extreme devotion of specialists, a great leap has been made in the field development. Clinicians and scientists gathered in The European Neuroendocrine Tumour Society publish current proposals for diagnosis solutions, together with the most up-to-date methods of treatment, which we have attempted to present in this general overview. It describes general methods of treating patients with GEP NET, as well as discusses ways of dealing with cases of tumours type foregut, midgut and hindgut.
Kos-Kudła
Beata
B
Division of Endocrinology, Department of Pathophysiology and Endocrinology, Zabrze, Medical University of Silesia, Katowice. endoklin@slam.katowice.pl
Zemczak
Anna
A
D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood*; D018276:Carcinoma, Medullary / Q000628:therapy; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*; D006801:Humans; D007414:Intestinal Neoplasms / Q000628:therapy; D018358:Neuroendocrine Tumors / Q000175:diagnosis* / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000628:therapy; D011379:Prognosis; D013274:Stomach Neoplasms / Q000628:therapy; D013964:Thyroid Neoplasms / Q000628:therapy
D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen